283 related articles for article (PubMed ID: 35666610)
21. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
22. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
[TBL] [Abstract][Full Text] [Related]
23. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
Wu J; Wu Y; Luo Y; Li X; Lin N; Yang X; Lin Y; Chen M
Ann Clin Lab Sci; 2020 Mar; 50(2):219-227. PubMed ID: 32366560
[TBL] [Abstract][Full Text] [Related]
24. Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma.
Wu X; Wan R; Ren L; Yang Y; Ding Y; Wang W
Turk J Gastroenterol; 2022 Oct; 33(10):844-851. PubMed ID: 35943150
[TBL] [Abstract][Full Text] [Related]
25. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
26. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus.
Tan Y; Ge G; Pan T; Wen D; Chen L; Yu X; Zhou X; Gan J
PLoS One; 2014; 9(9):e107986. PubMed ID: 25238238
[TBL] [Abstract][Full Text] [Related]
27. Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma.
El-Naidany SS; Zid E; Reda FM; Nada A; Fouda EAM
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2687-2693. PubMed ID: 36037122
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients.
Eldosoky MA; Hammad R; Elmadbouly AA; Aglan RB; Abdel-Hamid SG; Alboraie M; Hassan DA; Shaheen MA; Rushdi A; Ahmed RM; Abdelbadea A; Abdelmageed NA; Elshafei A; Ali E; Abo-Elkheir OI; Zaky S; Hamdy NM; Lambert C
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834570
[TBL] [Abstract][Full Text] [Related]
29. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
30. Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma.
Weis A; Marquart L; Calvopina DA; Genz B; Ramm GA; Skoien R
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781550
[TBL] [Abstract][Full Text] [Related]
31. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
33. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.
Zhang ZQ; Meng H; Wang N; Liang LN; Liu LN; Lu SM; Luan Y
Diagn Pathol; 2014 Jul; 9():135. PubMed ID: 24993656
[TBL] [Abstract][Full Text] [Related]
34. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
Wang F; Ying H; He B; Pan Y; Sun H; Wang S
Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
[TBL] [Abstract][Full Text] [Related]
35. Detection of exosomal miR-18a and miR-222 levels in Egyptian patients with hepatic cirrhosis and hepatocellular carcinoma.
Elghoroury EA; Abdelghaffar EE; Awadallah E; Kamel SA; Kandil D; Hassan EM; Hassan M; Kamel MM; Gomaa MM; Fathalla LA
Int J Immunopathol Pharmacol; 2022; 36():3946320221097832. PubMed ID: 35467432
[TBL] [Abstract][Full Text] [Related]
36. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma.
El-Hamouly MS; Azzam AA; Ghanem SE; El-Bassal FI; Shebl N; Shehata AMF
Mol Biol Rep; 2019 Dec; 46(6):5759-5765. PubMed ID: 31471732
[TBL] [Abstract][Full Text] [Related]
37. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
[TBL] [Abstract][Full Text] [Related]
38. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Liu WH; Ren LN; Wang X; Wang T; Zhang N; Gao Y; Luo H; Navarro-Alvarez N; Tang LJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1767-78. PubMed ID: 25724413
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
40. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
